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We analyzed nine multigenerational families with ascertained affective spectrum disorders in northern Sweden’s
geographically isolated population of Va¨sterbotten. This northern Swedish population, which originated from a
limited number of early settlers ∼8,000 years ago, is genetically more homogeneous than outbred populations. In
a genomewide linkage analysis, we identified three chromosomal loci with multipoint LOD scores (MPLOD) 2
at 9q31.1-q34.1 (MPLOD 3.24), 6q22.2-q24.2 (MPLOD 2.48), and 2q33-q36 (MPLOD 2.26) under a recessive
affected-only model. Follow-up genotyping with application of a 2-cM density simple-tandem-repeat (STR) map
confirmed linkage at 9q31.1-q34.1 (MPLOD 3.22), 6q23-q24 (MPLOD 3.25), and 2q33-q36 (MPLOD 2.2). In
an initial analysis aimed at identification of the underlying susceptibility genes, we focused our attention on the
9q locus. We fine mapped this region at a 200-kb STR density, with the result of an MPLOD of 3.70. Genealogical
studies showed that three families linked to chromosome 9q descended from common founder couples ∼10 gen-
erations ago. In this ∼10-generation pedigree, a common ancestral haplotype was inherited by the patients, which
reduced the 9q candidate region to 1.6 Mb. Further, the shared haplotype was observed in 4.2% of patients with
bipolar disorder with alternating episodes of depression and mania, but it was not observed in control individuals
in a patient-control sample from the Va¨sterbotten isolate. These results suggest a susceptibility locus on 9q31-q33
for affective disorder in this common ancestral region.
Introduction
Bipolar disorder (BP, also known as “manic depression”
[MIM 125480]) is characterized by alternating episodes
of depression and mania (BPI) or hypomania (BPII),
whereas recurrent unipolar depression (UPR) is charac-
terized by recurrent episodes of depression without epi-
sodes of mania. BP and UPR are part of a spectrum of
affective disorders that also includes major depression,
cyclothymia, dysthymia, and schizoaffective bipolar dis-
order. Affective disorders are a major public health con-
cern, because of a high lifetime prevalence (0.5%–1.5%
for BP; 9.5% for UPR) and a high rate of morbidity and
mortality (Mu¨ller-Oerlinghausen et al. 2002). Twin, adop-
tion, and family studies support a strong genetic compo-
nent (Craddock and Jones 1999; Smoller and Finn 2003);
the heritability of BP was estimated at 80%.
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Since the pathophysiology of affective disorders is still
unknown, linkage analysis is one method of identifi-
cation of chromosomal regions and genes that might be
involved in the etiology of BP. A major problem in link-
age studies is the high degree of genetic heterogeneity
among patients with affective spectrum disorders. The
complex genetic etiology of affective disorders might
explain the finding in independent linkage studies of
several chromosomal regions, such as 1q31-32, 4p16,
6pter-p24, 10p14, 10q21-26, 12q23-24, 13q31-32,
18p11, 18q21-23, 21q22, 22q11-13, and Xq24-28 (re-
viewed by Baron [2002]).
Families originating from a population isolate are pre-
dicted to reduce the genetic complexity and potentially
also the environmental background (Peltonen 2000).
Therefore, fewer susceptibility alleles are expected in an
isolated population for any complex disorder, and en-
vironmental factors are probably more homogeneous,
which improves the chance of finding susceptibility loci
and genes. The advantage of studying families originat-
ing from an isolated population has been proven earlier,
with the promising findings of neuregulin 1 (NRG1)
and D-amino-acid oxidase activator (earlier referred to
as “G72”), for which initial significant linkage was
found on 8p and 13q in analysis of Icelandic (Stefansson
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Table 1
MLINK Two-Point Linkage Results,
under Dominant and Recessive Models,
for Markers Showing a LOD Score 1.2
in at Least One Model
MARKER
LOD SCORE FOR
Dominant
Model
Recessive
Model
Zmax vmax Zmax vmax
D2S326 1.91 .01 0.80 .20
D2S2248 .51 .20 1.94 .00
D2S126 1.71 .05 1.76 .01
D2S396 1.74 .10 1.29 .05
D4S415 1.43 .01 1.46 .05
D5S418 1.336 .00 .52 .10
D6S262 .27 .40 1.50 .01
D6S308 .00 .10 2.27 .00
D9S289 1.07 .10 2.17 .00
D9S155 1.55 .05 2.60 .00
D9S290 .33 .20 2.21 .00
D12S326 .02 .30 1.65 .00
D12S346 .81 .20 1.58 .00
D12S78 .82 .10 1.202 .05
D14S63 .53 .10 1.98 .00
D17S785 .32 .20 1.83 .00
D18S61 1.02 .10 1.64 .00
D20S100 .40 .20 1.37 .05
NOTE.—Markers with a LOD score1.2
are indicated in bold italics.
et al. 2002) and French Canadian families (Chumakov
et al. 2002), respectively. The families used in the pres-
ent linkage-analysis study were ascertained in northern
Sweden. The current northern Swedish population is an
old population with geographical isolation and a low
immigration rate; therefore, it is considered a popula-
tion isolate (Nylander and Beckman 1991). Because of
reduced genetic variation, genomewide scans in families
from northern Sweden have already been successful in
identification of susceptibility loci in complex diseases
such as schizophrenia (SZ) (Lindholm et al. 2001).
Here, we present genomewide significant linkage in nine
families ascertained through a proband with BPI or UPR
and several family members with phenotypes within the
affective disorder spectrum.
Material and Methods
Samples
Fourteen families originating from the region of Va¨s-
terbotten in northern Sweden who segregated BP or UPR
were ascertained at Umea˚ University Hospitals. The fami-
lies were ascertained through probands with BPI or UPR.
Of the 14 families, 5 were included in a linkage study
of UPR (Balciuniene et al. 1998). In our study, the re-
maining nine multigenerational families with at least one
family member with BPI were selected, comprising 365
individuals, of whom 60 were affected (fig. A1 [online
only]). In each family, the proband was affected with
BPI or UPR. In total, 171 persons from the nine families
were examined. The following affective spectrum diag-
noses were obtained in 46 patients: BPI (19), BPII (6),
UPR (18), and schizoaffective disorder–bipolar type
(SAM) (3) (table A1 [online only]). For 116 of the 171
individuals, the structured interview revealed no lifetime
history of psychiatric disorders; therefore, they were con-
sidered healthy. Nine individuals obtained a diagnosis of
other psychiatric disorders. For 16 individuals, no in-
terview could be obtained. Three spouses had an affec-
tive spectrum diagnosis: one was diagnosed with BPI,
whereas two had UPR.
A sample of 182 unrelated patients with BPI and 182
unrelated control individuals, originating from the same
Va¨sterbotten region, were randomly ascertained at Umea˚
University Hospitals in northern Sweden. The sex ratio
of the patient group was 96 females:86 males, the mean
age at inclusion was 56.3 years, and the mean age at
disease onset was 30.8 years. The control group was
matched with the patient group according to age and
sex. These individuals stem from the Betula project, a
large population-based prospective study described in
detail elsewhere (Nilsson et al. 1997). In the present
study, individuals with a lifetime history of psychotic
disorders were excluded. The sex ratio of the control
group was 90 females:92 males, and the mean age was
59.5 years.
All individuals were aged18 years and gave informed
consent, after approval of the study by the Medical Ethi-
cal Committee of the University of Umea˚. Medical re-
cords were available for all patients; records were exam-
ined by experienced psychiatrists and classified according
to DSM-IV criteria. The diagnoses were confirmed using
the relevant chapters of the Schedules for Clinical As-
sessment in Neuropsychiatry (Wing et al. 1990). The
medical ethical committees of the University of Umea˚
and the University of Antwerp approved the inclusion
of the patients, their relatives, and control individuals
in genetic studies.
Genotyping
From each participant, a venous blood sample was ob-
tained, and genomic DNA was extracted using standard
procedures. DNA of 187 individuals of the nine families
with BP was included in a 10-cM density genomewide
scan by use of 380 fluorescent-labeled STR markers (de-
scribed in detail by Lindholm et al. [2001]). On the basis
of genetic distances (sex averaged) of the Marshfield map
(Center for Medical Genetics), the mean marker distance
was 9.34 cM.
Genetic fine mapping of the candidate chromosomal
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Figure 1 Genealogical ∼10-generation pedigree linking the three families—MD200, MD2, and D28—to common founders. Blackened
symbols represent patients.
regions was performed with STR markers selected from
the Marshfield (Center for Medical Genetics) or the DE-
CODE Icelandic genetic maps (Kong et al. 2002). In the
first 2-cM fine-mapping step, map order and distances
between markers were based on the genetic maps. A
second fine-mapping step was performed for chromo-
some 9 with 15 novel STR markers, identified using the
Sputnik program, to identify haplotype sharing (table A2
[online only]). Map order and distances between these
markers are based on physical distances. All PCR am-
plifications were performed under standard reaction con-
ditions in a total volume of 20 ml on a Primus HT, by
use of fluorescent-labeled primers. After 4–9 markers
were pooled, PCR products were sized on an ABI 3700
or ABI 3730 Sequencer (Applied Biosystems), and ge-
notypes were assigned using GENOTYPER version 2.1
or Genemapper version 3.0, respectively. The STR mark-
ers used in the fine mapping were genotyped for 91
northern Swedish control individuals, to estimate popu-
lation allele frequencies. Also, 25 STR markers in the
LOD1 interval of the 9q-region were genotyped in the
northern Swedish patient-control–association sample, to
investigate allelic and genotypic distributions and to fur-
ther investigate the shared haplotype among unrelated
patients and healthy individuals in the northern Swedish
population.
Statistical Analysis
Simulation analysis was performed using the SLINK
program (Ott 1989; Weeks et al. 1990), in which a
marker with eight equally frequent alleles was hypothe-
sized. We calculated the number of false positives; that
is, the number of times that the LOD score exceeded the
LOD score threshold of 1–6 under the assumption of
no linkage ( ) in 10,000 replicates. The datavp 0.50
indicated that a suggestive LOD score 1.2 could be
expected once in a genome scan and a significant LOD
score 2.4 once in 20 genome scans. To estimate the
statistical power of the family set, we performed four
simulation studies with 10,000 replicates, each under
dominant and recessive models, with the disease gene
located at recombination fraction from thevp 0.05
simulated marker, assuming either genetic homogeneity
or 10% genetic heterogeneity. An average maximum
LOD score of 2.80 was obtained under dominant and
240
Figure 2 Multipoint linkage data of the genomewide scan for each chromosome. The black dashed curve represents MPLODs under the
dominant model, the solid black curve MPLODs under the recessive model; the gray curve represents NPL scores; and the gray dashed curve
represents the STR marker informativity. Genetic distances are based on the Marshfield genetic map (Center for Medical Genetics).
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Table 2
Genomewide Multipoint Parametric and Maximum NPL Scores
CHROMOSOME
REGION
(cM)
FINDINGS FOR
Parametric
Linkage
Nonparametric
Linkage
Dominant Recessive NPL P
2q33-q35 32 2.35 2.26 2.93 .0085
6q22.2-q24.2 29 !0 2.48 1.08 .1219
9q31.1-q34.1 26 .53 3.24 2.51 .0157
NOTE.—LOD scores 2.2 are indicated in bold italics.
recessive models, under the assumption of genetic ho-
mogeneity. There was 55% and 85% power to obtain
significant (LOD score 2.4) and suggestive (LOD 
1.2) linkage, respectively. Under the assumption of 10%
genetic heterogeneity, average maximum LOD scores of
2.35 and 2.39 were obtained, under dominant and re-
cessive models, respectively. Under the dominant model,
we obtained 44% and 75% power, whereas, under the
recessive model, we obtained 45% and 79% power to
detect significant and suggestive evidence for linkage,
respectively.
Two-point parametric linkage analysis was performed
using the MLINK program (Lathrop and Lalouel 1984).
Nonparametric allele-sharing statistics (nonparametric
LOD [NPL] scores and corresponding P values), mul-
tipoint parametric linkage analysis, and haplotype re-
construction were performed using the GENEHUNTER
software package beta version 2.1_r2 (Kruglyak et al.
1996; Kruglyak and Lander 1998). Linkage analysis was
performed under an affected-only model, with patients
phenotypes among the BP spectrum disorders. Relatives
without psychiatric symptoms, with other psychiatric
disorders, or who were not interviewed were considered
“unknown.” The phenocopy rate or percentage of pa-
tients with phenotypes unrelated to the genetic defect in
a family was defined differently for BPI and SAM (1%),
BPII (2%), and UPR (5%), in agreement with the popu-
lation frequencies of those disorders. The disease-allele
frequency in the general population was set at 0.01 and
0.10 for the dominant and recessive models, respectively.
In the genomewide linkage analysis, STR-allele fre-
quencies were estimated on the basis of married-in in-
dividuals in the pedigree, whereas, in the candidate re-
gions, STR allele frequencies were estimated on the basis
of 91 healthy unrelated individuals ascertained in the
Va¨sterbotten region. Allelic and genotypic distribution
of the 25 STR markers, in the LOD1 interval of the
9q-region, in the northern Swedish association sample
was investigated using GENEPOP version 3.3 (Raymond
and Rousset 1995). EHPLUS (Zhao et al. 2000) was
used to estimate haplotype frequencies in the patient-
control association sample.
Results
Linkage Analysis
The families used in the 10-cM density genomewide
linkage study were ascertained in northern Sweden, a re-
gion that is characterized by geographical isolation and
low immigration rate and considered a population iso-
late (Nylander and Beckman 1991). Moreover, church
records and national registers were available, and ge-
nealogy studies showed that three families—MD200,
MD2, and D28—descended from common founders ∼10
generations ago (fig. 1).
Linkage analysis resulted in suggestive two-point LOD
scores 1.2 with 18 markers on 10 chromosomes—2q,
4q, 5q, 6q, 9q, 12q, 14q, 17q, 18q, and 20q (table 1).
D9S289, D9S155, and D9S290 were neighboring mark-
ers only on chromosome 9 and showed LOD scores2.
The multipoint linkage plots for nonparametric and para-
metric (under dominant and recessive models) affected-
only analyses are shown per chromosome in figure 2. In
eight chromosomal regions—2q, 3p, 4q, 5q, 6q, 9q, 12q,
and 15p—suggestive multipoint LOD scores (MPLOD)
1.2 were calculated. Chromosomes 6q and 9q had a
significant MPLOD 2.4, under the recessive linkage
model, with highest scores at chromosome 9q, which
showed an MPLOD of 3.24 corresponding to a candi-
date region of 26 cM (115–141 cM from 9pter) within
the LOD1 interval (table 2). Chromosome 6q had an
MPLOD of 2.48, with a LOD1 candidate region ex-
tending over 29 cM 133–162 cM from 6pter. A near-
significant MPLOD of 2.26 was also observed for chro-
mosome 2q, with a LOD1 interval of 32 cM 198–229
cM from 2pter.
The chromosome 2q, 6q, and 9q regions were further
analyzed, using additional STR markers selected from
public genetic maps, to an overall marker density of 2
cM (fig. 3), and were statistically analyzed under the re-
cessive affected-only parametric model. This resulted in
(1) an MPLOD of 3.22 at 124 cM from 9pter and a can-
didate region of 10 cM between D9S289 and D9S258
(121–131 cM) (fig. 3A), (2) an MPLOD of 3.25 at 146
cM from 6pter and a 3-cM candidate region between
D6S310 and D6S1654 (144–147 cM) (fig. 3B), and (3)
an MPLOD of 2.16 at 200 cM from 2pter and a can-
didate region of 23 cM between D2S374 and D2S2197
(198–221 cM) (fig. 3C).
Identical-by-Descent Mapping at Chromosome
9q31.1-q34.1
Families MD200, MD2, and D28, who descended from
common founder couples (fig. 1), contributed a consid-
erable part to the linkage peak at chromosome 9q (table
3). To identify haplotype sharing among these families,
Figure 3 Multipoint linkage analyses for 2-cM STR density genotyping in the 9q (A), 6q (B), and 2q (C) regions, showing the MPLOD
curve for the recessive model (black curve). For the genetic fine mapping on chromosomes 9q, 6q, and 2q, we used an additional 16, 19, and
21 STR markers. STR markers flanking the LOD1 candidate region on each chromosome are indicated. The gray curve indicates the
informativity of the STR markers in the region.
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Table 3
Results of Fine Mapping Chromosomal Loci 9q, 6q, and 2q under a Recessive Model
CHROMOSOME
PEAK
(cM)
RESULTS OF FINE MAPPING UNDER A RECESSIVE MODEL
Parametric Multipoint Linkage
Nonparametric
Linkage
MD15 MD200 MD17 MD2 MD205 MD5H MD5U D28 D29 MPLOD aa HLODb NPL Pc
9q31.1-q34.1 124 .12 .88 .29 .63 .71 .24 .00 .46 .47 3.22 1.00 3.22 1.68 .05
6q22.2-q24.2 146 .09 .87 .44 1.02 .70 .17 .00 .49 .45 3.25 1.00 3.25 1.44 .08
2q33-q35 200 .09 .73 .50 .99 .70 .24 .00 .70 .32 2.16 .90 2.20 2.09 .03
NOTE.—Families MD200, MD2, and D28 descend from common founders ∼10 generations ago.
a a p homogeneity parameter of the estimated proportion of families linked to a locus.
b HLOD p heterogeneity LOD score.
c P value at linkage peak.
Figure 4 Multipoint linkage data for the 200-kb STR fine mapping in the 9q region, showing MPLODs for the recessive model (black
curve). The gray curve indicates the STR marker informativity.
18 additional STR markers were selected, using the Sput-
nik program, to obtain a marker density of 200 kb in
and around the 10-cM candidate region. Statistical an-
alysis under the recessive model resulted in an MPLOD
of 3.70 at TV9S011, located 122.9 cM from 9pter (fig.
4). The candidate region further decreased to 4 cM be-
tween markers TV9S001 at 122 cM and TV9S002 at
126 cM. Haplotypes were reconstructed for all individu-
als in the families, to identify haplotype sharing among
patients in these families. Figure 5 shows the patients’
haplotypes in the LOD1 interval at chromosome 9q.
This enabled the identification of the 5-marker haplo-
type 1-1-2-5-1, shared identical by descent by 18 of
the 21 patients, between TV9S014 and TV9S017 in a
1.6-Mb region. Incomplete sharing (11/24 [46%] chro-
mosomes) was observed at D9S754, mapped between
D9S1802 and TVS016.
Association Analysis at Chromosome 9q31.1-q34.1
For chromosome 9, allelic and genotypic distribution
of 25 STR markers in and around the LOD1 interval
of the 9q-region, with a spacing of ∼200 kb, were in-
vestigated in the northern Swedish BPI-association pa-
tient-control sample; P values are shown in table 4.
Markers D9S1824 and D9S18642, separated by a dis-
tance of ∼6.5 cM, yielded P values .05. Allele 5 of
D9S1864 is contained in the shared haplotype segre-
gating in families MD200, MD2, and D28. D9S1802,
also contained in the shared haplotype, shows a trend
toward association ( ). EHPLUS was used to es-Pp .06
timate the frequency of five-marker haplotype 1-1-2-5-
1 in the association sample. The haplotype was present
in 4.2% of the patients with BPI but was absent in 182
unrelated control individuals (frequency !0.5%).
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Figure 5 Haplotype analysis in the LOD1 interval on chromosome 9q. Only haplotypes with allele sharing between patients of the
three families MD200, MD2, and D28 in the multigenerational pedigree are shown (indicated by gray shading). MPLODs corresponding to
physical distance (kb) and allele frequencies (freq) of the shared alleles are given.
Discussion
We present genomewide linkage results for affective spec-
trum disorders in nine multigenerational families with
BP ascertained in the population isolate of Va¨sterbotten
in northern Sweden. On the basis of the simulated sig-
nificance LOD-score thresholds in the nine families with
BP, two loci, one on 9q (MPLOD 3.24) and one on 6q
(MPLOD 2.48), showed MPLODs of genomewide sig-
nificance (2.4), whereas one locus at 2q was close to
significance (MPLOD 2.26). After fine mapping at 2-cM
STR density, the two susceptibility regions on 9q and
6q showed MPLODs 3.2 that are close to the Lander
and Kruglyak (1995) levels of genomewide significance
(MPLOD 3.3). The LOD1 candidate regions were
10 cM for 9q31.1-q34.1 (MPLOD 3.22) and 3 cM for
6q23-q24.3 (MPLOD 3.25). The third region at 2q33-
2q36 remained suggestive, with an MPLOD of 2.2 and
a LOD1 candidate region of 23 cM. For all three loci,
the highest LOD scores were obtained under the reces-
sive affected-only model, which might reflect the high
degree of inbreeding in this isolated population rather
than a true recessive inheritance. This is, for example,
evidenced by the observation that the chromosome 9q
shared haplotype appeared homozygous as well as het-
erozygous in different patients of the ∼10-generation ge-
nealogical pedigree (figs. 1 and 5).
Interestingly, Lindholm et al. (2001) found significant
genomewide linkage for an SZ susceptibility locus at
6q25, slightly more telomeric than our region 6q23-
q24. The patients of the 12-generation family ascer-
tained in the same geographic region in northern Swe-
den inherited a common ancestral haplotype (Lindholm
et al. 2004). Patients received diagnoses within the
“broad spectrum of SZ,” including SZ, psychoses not
otherwise specified, schizoaffective disorder depressed
type, and schizoaffective disorder bipolar type. Also in
our study, 72% of the patients with BP and schizoaf-
fective patients had psychotic features. Therefore, we
cannot exclude sharing at the 6q locus between this
extended pedigree with SZ and some of the nine families
with BP included in our study. Linkage of BP and SZ
to 6q has also been observed in several other ethnic
population—including isolated populations of Portu-
guese and Arab Israeli origin, as well as outbred popula-
tions of American, Danish, and Austrian origin—which
indicates that a gene or genes at 6q might contribute
considerably to the risk of psychiatric disease (Bailer et
al. 2002; Ewald et al. 2002; Dick et al. 2003; Lerer et
al. 2003; Middleton et al. 2004). Also, chromosome 2q
has been linked to BP as well as SZ in a number of
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Table 4
Results of Chromosome 9q Association Study
LOCUS
P VALUE FOR
Allelic
Differentiation
Genotypic
Differentiation
D9S1824 .01526 .0218
TV9S008 .4773 .544
TV9S001 .25324 .3693
TV9S010 .18651 .1741
D9S51 .30601 .3401
D9S155 .71646 .6744
D9S1776 .86383 .8759
TV9S011 .45454 .4252
D9S177 .71948 .7162
TV9S013 .44365 .4505
D9S170 .62938 .6487
TV9S014 .9547 .961
D9S1802 .09107 .0601
D9S754 .42837 .4322
TV9S016 .89654 .8938
D9S1864 .0271 .0401
TV9S017 .40054 .3447
TV9S002 .48055 .5029
D9S1848 .17911 .0908
TV9S020 .78411 .7702
TV9S003 .09762 .0697
D9S258 .43362 .3625
TV9S004 .58749 .5954
TV9S005 .40008 .3469
D9S1682 .0964 .0917
NOTE.—P values .05 are indicated in bold italics.
studies in regions that are either centromeric (Cichon
et al. 2001; Ewald et al. 2003) or telomeric (Paunio et
al. 2001; Bennet et al. 2002; Wijsman et al. 2003) to
the region we identified in the Swedish families with BP.
In a first step toward identifying the underlying sus-
ceptibility genes, we focused our attention first on the
chromosome 9q31.1-q34.1 region that had the highest
two-point and multipoint LOD scores in the genome-
wide scan. Also, our chromosome 9q signal overlaps
with previous BP findings (Detera-Wadleigh et al. 1997;
Badenhop et al. 2002; Liu et al. 2003; Shink et al. 2004).
Further, significant evidence for linkage was found in
Icelandic families, where patients diagnosed with anxiety
and panic disorder showed a high comorbidity with
mood disorders (Thorgeirsson et al. 2003). Though the
data for the nine families were included, the 9q region
was not supported by the two meta-analyses of ge-
nomewide scan data (Badner and Gershon 2002; Se-
gurado et al. 2003). This does not exclude our linkage
observation, since affective disorders have a complex
etiology with a high degree of genetic heterogeneity that
differs between populations.
In the northern Swedish population isolate, different
genes might be responsible for the expression of the
disease phenotype. In fact, in this isolated population,
it is more likely that families have a similar underlying
genetic defect that helps in the detection of a particular
gene. This is exemplified by the observation that three
of the families that contributed most to the 9q linkage
finding are descendants of a few founding couples ∼10
generations ago (fig. 1).
We further narrowed the 9q region by linkage analy-
ses, using known and novel STR markers at a 200-kb
density. A significant MPLOD of 3.70 was obtained, and
the candidate region was reduced to a region of 4 cM
cytogenetically located on 9q31-q33. In the three fami-
lies that descended from common founders, a shared
five-marker haplotype between TV9S014 and TV9S017
was observed in 18 of the 21 (85.7%) patients, which
narrows the candidate region to 1.6 Mb. Of the eight
patients with BPI, five were homozygous for the shared
haplotype and two were heterozygous. The remaining
patient with BPI, his sister with UPR (family D28), and
one other patient with UPR (family MD2) did not seg-
regate the shared haplotype. This might be attributed
to the complexity of the affective spectrum phenotypes,
with difficulties in diagnostic classification and specifi-
cation of spectrum boundaries. Further, one marker,
D9S754, did not contribute to the haplotype sharing.
Careful examination of the data, as well as retyping,
excluded genotype errors. This finding might argue
against a shared haplotype, but the absence of the
shared haplotype, estimated in a population of 182 un-
related control individuals from Va¨sterbotten by use of
EHPLUS (Zhao et al. 2000), makes it unlikely that this
is a sharing by chance rather than a true observation.
Furthermore, EHPLUS analysis of the shared haplotype
in a sample of 182 patients showed that this haplotype
was present in 4.2% of the patients with BPI. Therefore,
the most likely explanation is that D9S754 is meiotically
unstable or that it is located in a recombinational hot-
spot region, so that multiple mutations have occurred
(Strand et al. 1993; Majewski and Ott 2000; Ellegren
2004).
In summary, we identified three susceptibility loci for
affective disorders with significant linkage at 9q31-q33
and 6q23-q24 and with suggestive linkage at 2q33-q36
in a northern Swedish population isolate. Furthermore,
we were able to find a shared ancestral haplotype at
9q31-q33.
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